Albuminuria Clinical Trial
Official title:
Effects of Intensive Low-Salt Diet Education by Mobile Application on Albuminuria
Albuminuria is a known risk factor for cardiovascular disease (CVD), chronic kidney disease
(CKD) progression, all cause mortality. Inhibition of the renin-angiotension-aldosterone
system (RAAS) plays an important role in the reduction of albuminuria and preservation of
renal function in patients with CKD and it is known that the daily intakes of sodium have a
significant effect on the activity of RAAS. Dietary sodium restriction has been shown to
enhances the blood pressure, albuminuria, and renal function preservation. Furthermore,
recent study has shown that intensive low-salt dietary education reduces albuminuria in
patients with CKD. The average sodium intake of Koreans is 4,791 mg/d, which is higher than
other countries. It is difficult for medical staff in Korea to invest enough time in low salt
diet.
Recently, the development of health-related applications (apps) has been carried out
worldwidely, and researches on lifestyle improvement using apps have been actively studied.
However, there is no research yet on whether intensive education using an apps can affect
lifestyle habits and thus changes in actual new features. Smartphone apps may provide an
alternative to resource-intensive low salt diet-education. Therefore, this study aims to
investigate the effect of intensive low salt diet training on the changes of albuminuria
using application.
This is an pen-label, case-control, randomized clinical trial.
- Run-in period (8 weeks) : before 8 weeks of study initiation, all of the patients have
to stop all RAAS blockers or diuretics and switch to antihypertensive agents of other
categories such as calcium channel blockers.
- 0-8 weeks : After run-in period, the patients complete laboratory examination and a dish
frequency questionnaire. From 0 weeks, all participants will be prescribed valsartan
80mg per day until the end of study.
- 8-16 weeks : After 8 weeks, the patients will be randomly assigned to receive an
low-salt dietary intervention after second laboratory examination.
Usual education : Conventional education at an outpatient clinic Intensive education : Low
salt diet education through Smartphone app
The patients in the conventional education group will receive routine CKD education once at
an outpatient clinic. Otherwise, the patients in the intensive education group will be
trained low salt diet through smartphone app.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00095290 -
Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria
|
Phase 4 | |
Completed |
NCT02144740 -
Effect of NWT-03 on Blood Pressure
|
N/A | |
Completed |
NCT01041599 -
Correlation of Albuminuria With Arterial Stiffness
|
N/A | |
Active, not recruiting |
NCT05321095 -
Screening for Albuminuria at the First Line for Early Identification of CKD
|
||
Completed |
NCT02945969 -
Sodium Lowering and Urinary Protein Reduction Trial
|
Phase 3 | |
Enrolling by invitation |
NCT04295889 -
Towards HOMe-based Albuminuria Screening: an Implementation Study Testing Two Approaches
|
N/A | |
Recruiting |
NCT04272359 -
Substitution of Sulfonylureas With New Generation of Hypoglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus
|
||
Completed |
NCT03889236 -
Dietary Interventions on Glycocalyx Dimensions in South Asian Patients With Diabetic Nephropathy.
|
N/A | |
Active, not recruiting |
NCT00625820 -
Tetrahydrobiopterin in Patients With Chronic Kidney Disease (CKD) and Albuminuria
|
Phase 2 | |
Recruiting |
NCT04752293 -
Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)
|
||
Completed |
NCT03118739 -
Intensive Uric Acid Lowering With Verinurad and Febuxostat in Patients With Albuminuria
|
Phase 2 | |
Completed |
NCT06374043 -
Decentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozin.
|
Phase 4 | |
Not yet recruiting |
NCT06094920 -
Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial
|
Phase 4 | |
Recruiting |
NCT00342927 -
Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
|
||
Completed |
NCT02689778 -
Effect of Pirfenidone on Glomerular Filtration Rate and Albuminuria in Patients With Diabetic Nephropathy
|
Phase 3 | |
Completed |
NCT02497300 -
Vascular Effects of Mineralocorticoid Receptor Antagonism in Kidney Disease
|
Phase 2 | |
Completed |
NCT02446548 -
Influence of Aliskiren on Albuminuria After Kidney Transplantation
|
N/A | |
Completed |
NCT01547897 -
NOX-E36 in Patients With Type 2 Diabetes Mellitus and Albuminuria
|
Phase 2 | |
Enrolling by invitation |
NCT01316068 -
Effect of Sulodexide on Albuminuria in Chinese Type 2 Diabetic Patients
|
Phase 4 | |
Completed |
NCT00312780 -
Study of XL784 in Patients With Albuminuria Due to Diabetic Nephropathy
|
Phase 2 |